Lixte Biotechnology Holdings, Inc. - Common Stock (LIXT)
2.2800
-0.1800 (-7.32%)
Lixte Biotech Holdings is a biotechnology company focused on the discovery and development of novel therapeutics for the treatment of cancer and other life-threatening diseases
The company specializes in cell death pathways, aiming to identify and advance drug candidates that can effectively target and disrupt these pathways to induce cancer cell death. By leveraging its proprietary technology and research, Lixte seeks to bring innovative solutions to the market, contributing to the advancement of cancer treatment and improving patient outcomes.
NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Lixte Biotechnology Holdings, Inc. (NASDAQLIXT) is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones index gaining over 300 points on Wednesday. The Dow traded up 0.78% to 39,589.55 while the NASDAQ fell 0.02% to 16,312.74. The S&P 500 also rose, gaining, 0.36% to 5,222.18.
Shares of LuxUrban Hotels Inc. (NASDAQLUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 200 points on Wednesday. The Dow traded up 0.56% to 39,502.25 while the NASDAQ fell 0.08% to 16,302.03. The S&P 500 also rose, gaining, 0.27% to 5,217.52.
The company announced the publication of pre-clinical data in the online journal, "Cancer Discovery", showing that its lead clinical compound, LB-100, can force cancer cells to give up their cancer-causing properties in a paper entitled "Paradoxical activation of oncogenic signaling as a cancer treatment strategy."
U.S. stocks traded higher this morning, with the Dow Jones gaining over 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.58% to 39,511.62 while the NASDAQ rose 0.60% to 16,412.89. The S&P 500 also rose, gaining, 0.58% to 5,233.65.
Lixte Biotechnology Holdings, Inc. (NASDAQLIXT) is one today’s most active stocks by volume. So far today, approximately 22.95M shares of Lixte Biotechnology Holdings, Inc. have been exchanged, as compared to an average 30-day volume of 86,145 shares.
The Dow Jones closed lower by around 10 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
The Dow Jones closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Gainers Femasys Inc. (NASDAQFEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.
